|
TTC17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.23074900165921E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44249065417534E-15 |
| Normal-vs-Stage2 |
1.400220E-04 |
| Normal-vs-Stage3 |
1.36269999995164E-06 |
| Normal-vs-Stage4 |
5.78439999999736E-05 |
| Stage1-vs-Stage2 |
8.355200E-01 |
| Stage1-vs-Stage3 |
1.868000E-02 |
| Stage1-vs-Stage4 |
7.956200E-02 |
| Stage2-vs-Stage3 |
2.668400E-01 |
| Stage2-vs-Stage4 |
3.558200E-01 |
| Stage3-vs-Stage4 |
8.312800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65356617287671E-12 |
| Normal-vs-AfricanAmerican |
7.633600E-04 |
| Normal-vs-Asian |
7.217900E-02 |
| Caucasian-vs-AfricanAmerican |
3.327600E-01 |
| Caucasian-vs-Asian |
9.906400E-01 |
| AfricanAmerican-vs-Asian |
7.137600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.61499719048197E-11 |
| Normal-vs-Female |
1.64102065269844E-12 |
| Male-vs-Female |
4.963600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.148000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.78546066820218E-12 |
| Normal-vs-Age(61-80Yrs) |
3.21019877347339E-11 |
| Normal-vs-Age(81-100Yrs) |
1.604350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.365580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.864200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.884000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.234400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.179800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.648400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.39389999999728E-05 |
| Normal-vs-Grade 2 |
1.62569957495862E-12 |
| Normal-vs-Grade 3 |
4.0783000310185E-09 |
| Normal-vs-Grade 4 |
3.564500E-03 |
| Grade 1-vs-Grade 2 |
4.956300E-02 |
| Grade 1-vs-Grade 3 |
1.797530E-03 |
| Grade 1-vs-Grade 4 |
9.576800E-04 |
| Grade 2-vs-Grade 3 |
7.444500E-03 |
| Grade 2-vs-Grade 4 |
2.124600E-03 |
| Grade 3-vs-Grade 4 |
1.960370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.21789999979671E-07 |
| ccA subtype-vs-ccB subtype |
4.35420000000075E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61390908917747E-12 |
| Normal-vs-N1 |
3.162800E-01 |
| N0-vs-N1 |
1.366590E-01 |
|
|
